Ionis Pharmaceuticals | IONS - Kewajiban Lancar





Kewajiban Lancar Perubahan Tanggal
Agios Pharmaceuticals USD 58.84M 23.36M 2026-03
Alnylam Pharmaceuticals USD 1.35B 116.87M 2026-03
Arrowhead Research USD 295.22M 52.2M 2026-03
Astellas Pharma JPY 1.22T 106.19B 2026-03
BioCryst Pharmaceuticals USD 195.39M 675K 2026-03
BioMarin Pharmaceutical USD 793.15M 34.12M 2026-03
Celltrion KRW 283.62B 3.72T 2025-12
Cspc Pharmaceutical CNY 10.18B 65.36M 2025-12
Deva Holding AS TRY 6.43B 1.18B 2023-09
Divis Laboratories Ltd INR 20.43B 3.15B 2026-03
Esperion Therapeutics USD 300.36M 451K 2026-03
Exelixis USD 370.98M 34.67M 2026-03
Halozyme Therapeutics USD 363.21M 186.12M 2026-03
Ionis Pharmaceuticals USD 717M 66M 2026-03
Kangmei Pharma CNY 5.38B 433.79M 2026-03
Knight Therapeutics CAD 165.26M 12.58M 2025-12
Laboratorios Farma EUR 199.84M 121.75M 2023-12
Malin Corporation EUR 1000K 500K 2024-12
Medical Developments International AUD 5.56M 2.26M 2025-12
Moderna USD 2.4B 408M 2026-03
Nektar Therapeutics USD 53.54M 12.8M 2025-12
Neuren Pharmaceuticals AUD 4.34M 3.58M 2025-12
Neurocrine Biosciences USD 831.7M 88.3M 2026-03
Novartis USD 31.37B 4.1B 2026-03
Omeros USD 85.5M 2.28M 2025-06
OPKO Health USD 146.68M 22.64M 2025-12
Organigram Holdings CAD 94.05M 32.11M 2025-12
Ovoca Bio EUR 186K 2.26M 2025-06
Pfizer USD 34.35B 2.64B 2026-03
Pharma Mar EUR 89.23M 4.65M 2026-03
PTC Therapeutics USD 923.6M 44.82M 2026-03
Qiagen NV USD 512.14M 461.26M 2025-12
Regeneron Pharmaceuticals USD 5.11B 739.3M 2026-03
Roche Holding CHF 28B 421M 2025-12
Sarepta Therapeutics USD 499.16M 596.13M 2026-03
Sartorius EUR 2.11B 145.8M 2026-03
Sino Biopharmaceutical CNY 24.85B 5.29B 2025-06
Tilray USD 259.32M 8.32M 2025-09
Ultragenyx Pharmaceutical USD 325M 59M 2026-03
Vertex Pharmaceuticals USD 3.88B 19.4M 2026-03
Zealand Pharma A/S 664.96M 513.61M 2025-12
Zz Pientze Pharmaceu CNY 2.28B 134.52M 2026-03